동물세포배양기술을 이용한 유전자재조합의약품 산업 현황과 발전 방안

• 영문명: A Strategy for Improvement of Recombinant Pharmaceutical Industry Using Animal Cell Culture Technology
• 발행기관: 대한약학회
• 저자명: 방규호(Kyu Ho Bang) 김경수(Kyeong Soo Kim)
• 간행물 정보: 『약학회지』제65권 제1호(2021년), 1~9쪽, 전체 9쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2021.02.28

영문 초록

This study was undertaken to suggest a strategy for improving the recombinant pharmaceutical industry using animal cell culture technology. The status of markets and policies of domestic and global biosimilar recombinant products and the media industry were investigated. Based on this investigation, we suggest seven ideas for improving technical development and the licensing, production, and market launch phases as a strategy for improving the recombinant pharmaceutical industry using animal cell culture technology.

목차

서 론(Introduction)

방 법(Methods)

결 과(Results)

고 찰(Discussion)

결 론(Conclusion)

감사의 말씀(Acknowledgment)

Conflict of Interest

References

키워드

Recombinant pharmaceutical industry animal cell culture technology strategy for improvement of biomedicine